Proteomics Market By Technology (Spectroscopy, Chromatography, Electrophoresis, Protein Microarrays, X-Ray Crystallography, and Others), By Software & Services (Bioinformatics Software & Services, and Core Proteomics Services), By Application By End-Users, By Region, Trends, Analysis and Forecast Till 2034

Proteomics Market size will grow from USD 37.0 Billion in 2024 to USD 380.7 Billion by 2034 and is projected to grow at a CAGR of 29.20%.

Proteomics can be defined as the study of proteomes. Proteomes are a set of proteins that are produced in a system, organism, or any biological context. Proteomes vary from cell to cell and change over some time. Proteomics is used in various applications, such as, to investigate protein expression, transcriptional and post-transcriptional studies, metabolic pathways, to study protein interaction in diseases, to study localization of sub-cellular proteins, etc. Proteomics is used to investigate where and when the protein is expressed, the rate at which proteins are produced, and degraded, and how proteins are modified. It is also used to find which proteins are the cause of cancer and various other biological problems.

                         For More Report Details, Download Free Sample PDF

The proteomics market is expected to grow at a significant CAGR during the forecast period.  Increasing research & development activities in the healthcare industries, rising demand for personalized medicines, and increasing activities of drug discovery are some of the important factors expected to contribute to the growth of the proteomics market during the forecast period. Rise in use of proteomics to study cancer genes and protein interaction in cancer genes is projected to drive the growth of the proteomics market across the world.

Factors such as the application of proteomics in the diagnosis of infectious diseases, technological advancement, increase in health care expenditure, rise in awareness, etc. are the other factors likely to boost the growth of the proteomics market during the forecast period. However, inadequate funding and lack of awareness regarding the application of proteomics in developing countries are anticipated to restrain the growth of the proteomics market during the forecast period. On the contrary, lucrative opportunities associated with biomarker identification and developments in mass spectrometry-based proteomics are anticipated to provide lucrative growth opportunities to the global market players.

The proteomics market is segmented based on instrumentation technology, services and software, application, and region.

Based on the instrumentation technology, the target market is segmented into spectroscopy, chromatography, electrophoresis, protein microarrays, x-ray crystallography, and others. The spectroscopy and protein microarray segments are also expected to grow at a high CAGR during the forecast period.  Based on services and software, the global market is classified into core proteomics services, and bioinformatics software and services. The core proteomics services accounted for the largest share of the proteomics market. These services form the basis of proteomics and are highly adopted at every stage of the proteome analysis.

In addition, a large number of services are being outsourced, which is driving their growth. Based on application, the target market is bifurcated into clinical diagnostics, drug discovery, and other applications. The clinical diagnostics segment accounted for the largest share of the proteomics market. This can be attributed to the increased understanding of the relevance of investigating and understanding patterns of protein expression for disease diagnostics and drug development.

Regional Insights:

Based on the region the proteomics market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in North America accounts highest revenue share to the proteomics market due to the growing demand for advanced medical technologies and the increasing geriatric population. Asia Pacific proteomics market is projected to register a high CAGR over the forecast period owing to the growing trend of increased understanding of structures of protein expression for drug development and diseases.

Report scope:

Proteomics Market, By Instrumentation Technology:

• Spectroscopy
• Chromatography
• Electrophoresis
• Protein Microarrays
• X-Ray Crystallography
• Others

Proteomics Market, By Services and Software:

• Core Proteomics Services
• Bioinformatics Software and Services

Proteomics Market, By Application:

• Clinical Diagnostics
• Drug Discovery
• Other Applications

Proteomics Market, By Region:

• North America
  • North America Proteomics  Market, By Instrumentation Technology
  • North America Proteomics  Market, By Country
  • Canada
  • U.S.
  • North America Proteomics  Market, By Application
  • North America Proteomics  Market, By Services and Software
    • Europe
      • Europe Proteomics  Market, By Instrumentation Technology
      • Europe Proteomics  Market, By Services and Software
      • Europe Proteomics  Market, By Application
      • Europe Proteomics  Market, By Country
        • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • Asia Pacific Proteomics  Market, By Instrumentation Technology
      • Asia Pacific Proteomics  Market, By Services and Software
      • Asia Pacific Proteomics  Market, By Application
      • Asia Pacific Proteomics  Market, By Country
        • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Latin America Proteomics  Market, By Instrumentation Technology
      • Latin America Proteomics  Market, By Services and Software
      • Latin America Proteomics  Market, By Application
      • Latin America Proteomics  Market, By Country
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • Middle East & Africa Proteomics  Market, By Instrumentation Technology
      • Middle East & Africa Proteomics  Market, By Services and Software
      • Middle East & Africa Proteomics  Market, By Application
      • Middle East & Africa Proteomics  Market, By Country
        • GCC
        • Israel
        • South Africa
        • Rest of Middle East & Africa

The key players operating the proteomics market involve:

Thermo Fisher Scientific, Inc., Agilent Technologies Inc., GE Healthcare, Bio-Rad Laboratories Inc., Danaher Corporation, Merck KGaA, Luminex Corporation, Bruker Corporation, Waters Corporation, PerkinElmer, Inc., and others. In October 2018, Waters Corporation launched its RenataDX Screening System. In October 2018, Thermo Fisher Scientific, Inc. (US) collaborated with Symphogen (Denmark) under which Symphogen will use the Thermo Scientific Q Exactive Plus Orbitrap liquid chromatography-tandem mass spectrometry (LC/MS/MS) system with its BioPharma Option to create, test, and validate platform workflows for intact and native mass analysis of therapeutic monoclonal antibody (mAb) mixture. In July 2018, Thermo Fisher Scientific, Inc. (US) launched the Quadrupole-Orbitrap Mass Spectrometer.

• Thermo Fisher Scientific, Inc.
• Agilent Technologies, Inc.
• GE Healthcare
• Bio-Rad Laboratories, Inc.
• Danaher Corporation
• Luminex Corporation
• Bruker Corporation
• Merck KGaA
• Waters Corporation
• PerkinElmer, Inc.